Download PDF
Erfahrungsheilkunde 2024; 73(02): 91-101
DOI: 10.1055/a-2264-3381
Praxis

Die Rolle der Mitochondrien im Immunmetabolismus

Kurt Mosetter
Vesalius GmbH, Myoreflextherapie-Ausbildung, URL: http://www.myoreflex.de/uebersichtsseite-ausbildung/grundkurse   Email: ausbildung@akademie.mosetter.de   ZiT, Zentrum für interdisziplinäre Therapien, URL: http://www.myoreflex.de/uebersichtsseite-praxen/zit-konstanz   Email: info@mosetter.de
› Author Affiliations
› Further Information
    Permissions and Reprints

Zusammenfassung

In den Traditionen der ayurvedischen und chinesischen Medizin werden Erkrankungen mit Schwächezuständen, Müdigkeit, Depression, Neurodegeneration und Immundysregulation über „stärkende Naturstoffe“, aufbauende Maßnahmen für die Darmgesundheit, die „Lebergesundheit“ und einen guten Stoffwechsel behandelt. Nicht die Bekämpfung der Erkrankungen, sondern die Stärkung des natürlichen Energiestoffwechsels sowie der Reparatur stehen dabei im Vordergrund. Eine antientzündliche Ernährung mit verkochtem Gemüse, Linsen, Kichererbsen, Blumenkohl, Brokkoli und der Verzicht auf Toxine, Konservierungs- und Geschmacksverstärker, Zucker, Fruchtzucker, Getreide und Kuhmilchprodukte wird flankiert mit der Gabe von Myrobalan, Heidelbeeren, Goji-Beeren, Curcumin, Ingwer, Ginseng, Arabinogalactanen, Grüntee-Extrakten, Boswellia, Curcumin, Granatapfel, Cordyceps, Reishi, Artemisia usw. Ein gesunder Darm soll über den Stoffwechsel und die Leber den Energiehaushalt aufbauen. Könnte die Unterstützung der mitochondrialen Funktionen eine entscheidende Schnittstelle zwischen einer mehr als 3000 Jahre alten Erfahrungsmedizin und der modernen „Mitochondrien-Medizin“ darstellen?

Abstract

In the traditions of Ayurvedic and Chinese medicine, illnesses with states of weakness, fatigue, depression, neurodegeneration, and immune dysregulation are treated with „strengthening natural substances“, restorative measures for intestinal health, „liver health“, and a good metabolism. The focus is not on fighting the diseases, but on strengthening the natural energy metabolism as well as the repair process. An anti-inflammatory diet with overcooked vegetables, lentils, chickpeas, cauliflower, broccoli and the avoidance of toxins, preservatives and flavor enhancers, sugar, fructose, cereals, and cow‘s milk products is accompanied by the administration of myrobalan, blueberries, goji berries, curcumin, ginger, ginseng, arabinogalactans, green tea extracts, boswellia, curcumin, pomegranate, cordyceps, reishi, artemisia, etc. A healthy intestine is supposed to build up the energy balance via the metabolism and the liver. Could the support of mitochondrial functions represent a crucial interface between more than 3000 years of empirical medicine and modern „mitochondrial medicine“?

Schlüsselwörter

Mitochondrien - Immunmetabolismus - Neurodegeneration - Immunsystem - Biogenese

Keywords

mitochondria - immunometabolism - neurodegeneration - immune system - biogenesis


Publication History

Article published online:
09 April 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Xie JH, Li YY, Jin J. The essential functions of mitochondrial dynamics in immune cells. Cell Molecul Immunol 2020; 17 (7) 712-721
    CrossrefPubMedGoogle Scholar
  • 2 Wang B, Huang M, Shang D. et al. Mitochondrial behavior in axon degeneration and regeneration. Front Aging Neurosci 2021; 13: 650038
    CrossrefPubMedGoogle Scholar
  • 3 Barshad G, Marom S, Cohen T. et al. Mitochondrial DNA transcription and its regulation: An evolutionary perspective. Trends Genet 2018; 34 (9) 682-692
    CrossrefPubMedGoogle Scholar
  • 4 Adlimoghaddam A, Albensi BC. The nuclear factor kappa B (NF-κB) signaling pathway is involved in ammonia-induced mitochondrial dysfunction. Mitochondrion 2021; 57: 63-75
    CrossrefPubMedGoogle Scholar
  • 5 Vidali S, Aminzadeh S, Lambert B. et al. Mitochondria: The ketogenic diet – A metabolism-based therapy. Int J Biochem Cell Biol 2015; 63: 55-59
    CrossrefPubMedGoogle Scholar
  • 6 Naviaux RK. Metabolic features and regulation of the healing cycle – A new model for chronic disease pathogenesis and treatment. Mitochondrion 2019; 46: 278-297
    PubMedGoogle Scholar
  • 7 Rodríguez-Nuevo A, Zorzano A. The sensing of mitochondrial DAMPs by non-immune cells. Cell Stress 2019; 3 (6) 195-207
    CrossrefPubMedGoogle Scholar
  • 8 Picard M. Energy transduction and the mind-mitochondria connection. Biochemist 2022; 44 (4) 14-18
    CrossrefPubMedGoogle Scholar
  • 9 Georgescauld F, Popova K, Gupta AJ. et al. GroEL/ES chaperonin modulates the mechanism and accelerates the rate of TIM-barrel domain folding. Cell 2014; 157 (4) 922-934
    CrossrefPubMedGoogle Scholar
  • 10 Morén C, de Souza RM, Giraldo DM. et al. Antioxidant therapeutic strategies in neurodegenerative diseases. Int J Molecul Sci 2022; 23 (16) 9328
    CrossrefPubMedGoogle Scholar
  • 11 Yi L, Maier AB, Tao R. et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: A randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Gero Sci 2023; 45 (1) 29-43
    PubMedGoogle Scholar
  • 12 Parikh S, Saneto R, Falk MJ. et al. A modern approach to the treatment of mitochondrial disease. Curr Treatm Opt Neurol 2009; 11 (6) 414-430
    CrossrefPubMedGoogle Scholar
  • 13 Palmeira CM, Teodoro JS, Amorim JA. et al. Mitohormesis and metabolic health: The interplay between ROS, cAMP and sirtuins. Free Rad Biol Med 2019; 141: 483-491
    CrossrefPubMedGoogle Scholar
  • 14 Branco AF, Ferreira A, Simões RF. et al. Ketogenic diets: From cancer to mitochondrial diseases and beyond. Eur J Clin Invest 2016; 46 (3) 285-298
    CrossrefPubMedGoogle Scholar
  • 15 Zhu H, Bi D, Zhang Y. et al. Ketogenic diet for human diseases: The underlying mechanisms and potential for clinical implementations. Sign Transduct Targ Ther 2022; 7 (1) 11
    CrossrefPubMedGoogle Scholar
  • 16 Yuan Z, Liu S, Song W. et al. Galactose enhances chondrogenic differentiation of ATDC5 and cartilage matrix formation by chondrocytes. Front Molecul Biosci 2022; 9: 850778
    CrossrefPubMedGoogle Scholar
  • 17 Zachariou V, Bauer CE, Seago ER. et al. Healthy dietary intake moderates the effects of age on brain iron concentration and working memory performance. Neurobiol Aging 2021; 106: 183-196
    CrossrefPubMedGoogle Scholar
  • 18 Lepretti M, Martucciello S, Burgos Aceves MA. et al. Omega-3 fatty acids and insulin resistance: Focus on the regulation of mitochondria and endoplasmic reticulum stress. Nutrients 2018; 10 (3) 350
    CrossrefPubMedGoogle Scholar
  • 19 Tessema B, Haag J, Sack U. et al. The determination of mitochondrial mass is a prerequisite for accurate assessment of peripheral blood mononuclear cells‘ oxidative metabolism. Int J Molecul Sci 2023; 24 (19) 14824
    CrossrefPubMedGoogle Scholar
  • 20 Naviaux RK. Metabolic features and regulation of the healing cycle – A new model for chronic disease pathogenesis and treatment. Mitochondrion 2019; 46: 278-297
    CrossrefPubMedGoogle Scholar
  • 21 Li Z, Lu S, Li X. The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury. Cell Molecul Life Sci 2021; 78 (15) 5731-5741
    CrossrefPubMedGoogle Scholar
  • 22 Tyszka M, Maciejewska-Markiewicz D, Biliński J. et al. Increased intestinal permeability and stool zonulin, calprotectin and beta-defensin-2 concentrations in allogenic hematopoietic cell transplantation recipients. Int J Molecul Sci 2022; 23 (24) 15962
    CrossrefPubMedGoogle Scholar
  • 23 Tanaka M, Szabó Á, Spekker E. et al. Mitochondrial impairment: A common motif in neuropsychiatric presentation The link to the tryptophan-kynurenine metabolic system?. Cells 2022; 11 (16) 2607
    CrossrefPubMedGoogle Scholar
  • 24 Savin VJ, McCarthy ET, Sharma R. et al. Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity. Translat Res 2008; 151 (6) 288-292
    CrossrefPubMedGoogle Scholar
  • 25 Wong SY, Gadomski T, van Scherpenzeel M. et al. Oral D-galactose supplementation in PGM1-CDG. Genet Med 2017; 19 (11) 1226-1235
    CrossrefPubMedGoogle Scholar
  • 26 Witters P, Tahata S, Barone R. et al. Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG. Genet Med 2020; 22 (6) 1102-1107
    CrossrefPubMedGoogle Scholar
  • 27 Kreider RB, Kalman DS, Antonio J. et al. International Society of Sports Nutrition position stand: Safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr 2017; 14: 18
    CrossrefPubMedGoogle Scholar
  • 28 Zheng J, Ni C, Zhang Y. et al. Association of regular glucosamine use with incident dementia: Evidence from a longitudinal cohort and Mendelian randomization study. BMC Med 2023; 21 (1) 114
    CrossrefPubMedGoogle Scholar
  • 29 Sharma H, Keith Wallace R. Ayurveda and epigenetics. Medicina (Lithuania) 2020; 56 (12) 687
    PubMedGoogle Scholar
  • 30 Hassan Bulbul MR, Uddin Chowdhury MN, Naima TA. et al. A comprehensive review on the diverse pharmacological perspectives of Terminalia chebula Retz. Heliyon 2022; 8 (8) e10220
    CrossrefPubMedGoogle Scholar
  • 31 Ahmed S, Ding X, Sharma A. Exploring scientific validation of Triphala Rasayana in Ayurveda as a source of rejuvenation for contemporary healthcare: An update. J Ethnopharm 2021; 273: 113829
    CrossrefPubMedGoogle Scholar
  • 32 Hassan FU, Rehman MS, Khan MS. et al. Curcumin as an alternative epigenetic modulator: Mechanism of action and potential effects. Front Genet 2019; 10: 514
    CrossrefPubMedGoogle Scholar
  • 33 Homolak J, Babic Perhoc A, Virag D. et al. D-galactose might protect against ionizing radiation by stimulating oxidative metabolism and modulating redox homeostasis. J Radiat Res 2023; 64 (4) 743-745
    CrossrefPubMedGoogle Scholar
  • 34 Ratovitski EA. Anticancer natural compounds as epigenetic modulators of gene expression. Curr Genom 2017; 18 (2) 175-205
    CrossrefPubMedGoogle Scholar
  • 35 Pradeepkiran JA, Hindle A, Kshirsagar S. et al. Are mitophagy enhancers therapeutic targets for Alzheimer‘s disease?. Biomed Pharmacother 2022; 149: 112918
    CrossrefPubMedGoogle Scholar
  • 36 Royston KJ, Paul B, Nozell S. et al. Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms. Experim Cell Res 2018; 368 (1) 67-74
    CrossrefPubMedGoogle Scholar
  • 37 Fairley LH, Lejri I, Grimm A. et al. Spermidine rescues bioenergetic and mitophagy deficits induced by disease-associated tau protein. Int J Molecul Sci 2023; 24 (6) 5297
    CrossrefPubMedGoogle Scholar
  • 38 Erbeldinger R, Welsch G, Ellermann A. et al. Phytopharmaka – Eine kompakte Orientierung. First line treatment – A natural way. Sportärzt Z Sportmed Ern 2023; 1: 82-83
    PubMedGoogle Scholar
  • 39 Liu XL, Wang YD, Yu XM. et al. Mitochondria-mediated damage to dopaminergic neurons in Parkinson’s disease (Review). Int J Molecul Med 2018; 41 (2) 615-623
    PubMedGoogle Scholar
  • 40 Bose A, Beal MF. Mitochondrial dysfunction in Parkinson’s disease. J Neurochem 2016; 139 (1) 216-231
    CrossrefPubMedGoogle Scholar
  • 41 Borsche M, Pereira SL, Klein C. et al. Mitochondria and Parkinson’s disease: Clinical, molecular, and translational aspects. J Parkinson Dis 2021; 11 (1) 45-60
    CrossrefPubMedGoogle Scholar
  • 42 Legati A, Ghezzi D. Parkinson’s disease, parkinsonisms, and mitochondria: The role of nuclear and mitochondrial DNA. Curr Neurol Neurosci Rep 2023; 23 (4) 131-147
    CrossrefPubMedGoogle Scholar
  • 43 Grünewald A, Kumar KR, Sue CM. New insights into the complex role of mitochondria in Parkinson’s disease. Progr Neurobiol 2019; 177: 73-93
    CrossrefPubMedGoogle Scholar
  • 44 Monzio Compagnoni G, Di Fonzo A, Corti S. et al. The role of mitochondria in neurodegenerative diseases: The lesson from Alzheimer’s disease and Parkinson’s disease. Molecul Neurobiol 2020; 57 (7) 2959-2980
    CrossrefPubMedGoogle Scholar
  • 45 Abrishamdar M, Jalali MS, Farbood Y. Targeting mitochondria as a therapeutic approach for Parkinson’s disease. Cell Molecul Neurobiol 2023; 43 (4) 1499-1518
    CrossrefPubMedGoogle Scholar
  • 46 Quntanilla RA, Tapia-Monsalves C. The role of mitochondrial impairment in Alzheimer’s disease neurodegeneration: The tau connection. Curr Neuropharm 2020; 18 (11) 1076-1091
    CrossrefPubMedGoogle Scholar
  • 47 Patergnani S, Fossati V, Bonora M. et al. Mitochondria in multiple sclerosis: Molecular mechanisms of pathogenesis. Int Rev Cell Molecul Biol 2017; 328: 49-103
    CrossrefPubMedGoogle Scholar
  • 48 Fetisova E, Chernyak B, Korshunova G. et al. Mitochondria-targeted antioxidants as a prospective therapeutic strategy for multiple sclerosis. Curr Med Chem 2017; 24 (19) 2086-2114
    CrossrefPubMedGoogle Scholar
  • 49 Varhaug KN, Vedeler CA, Tzoulis C. et al. Multippel sklerose – En mitokondriemediert sykdom? [Multiple sclerosis – A mitochondria-mediated disease?]. Tidsskrift Norske Laege 2017; 137 (4) 284-287
    CrossrefPubMedGoogle Scholar
  • 50 Bargiela D, Chinnery PF. Mitochondria in neuroinflammation – Multiple sclerosis (MS), Leber hereditary optic neuropathy (LHON) and LHON-MS. Neurosci Lett 2019; 710: 132932
    CrossrefPubMedGoogle Scholar
  • 51 Heidker RM, Emerson MR, LeVine SM. Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis. Neural Regen Res 2017; 12 (8) 1262-1267
    CrossrefPubMedGoogle Scholar
  • 52 Liu Y, Zhu X. Endoplasmic reticulum-mitochondria tethering in neurodegenerative diseases. Transl Neurodegen 2017; 6: 21
    CrossrefPubMedGoogle Scholar
  • 53 Campbell GR, Worrall JT, Mahad DJ. The central role of mitochondria in axonal degeneration in multiple sclerosis. Multiple Scl (England) 2014; 20 (14) 1806-1813
    CrossrefPubMedGoogle Scholar
  • 54 Kozin MS, Kulakova OG, Favorova OO. Involvement of mitochondria in neurodegeneration in multiple sclerosis. Biochemistry 2018; 83 (7) 813-830
    PubMedGoogle Scholar
  • 55 Rossmann MP, Dubois SM, Agarwal S. et al. Mitochondrial function in development and disease. Dis Models Mech 2021; 14 (6) dmm048912
    CrossrefPubMedGoogle Scholar
  • 56 He L, Maheshwari A. Mitochondria in early life. Curr Ped Rev 2023; 19 (4) 395-416
    CrossrefPubMedGoogle Scholar
  • 57 Lepretti M, Martucciello S, Burgos Aceves MA. et al. Omega-3 fatty acids and insulin resistance: Focus on the regulation of mitochondria and endoplasmic reticulum stress. Nutrients 2018; 10 (3) 350
    CrossrefPubMedGoogle Scholar
  • 58 Maksoud R, Balinas C, Holden S. et al. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome. J Translat Med 2023; 19 (1) 81
    CrossrefPubMedGoogle Scholar
  • 59 Jelinek G. Taking control of multiple sclerosis: Natural and medical therapies to prevent its progression. Lancaster: Fleetfoot Books; 2005
    Google Scholar
  • 60 Jelinek G. Overcoming multiple sclerosis: An evidence-based guide to recovery. Allen & Unwin; 2010
    Google Scholar
  • 61 Jelinek G. Recovering from multiple sclerosis: Real life stories of hope and inspiration. Allen & Unwin; 2013
    Google Scholar
  • 62 Patani R, Balaratnam M, Vora A. et al. Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol Appl Neurobiol 2007; 33 (3) 277-287
    CrossrefPubMedGoogle Scholar
  • 63 Kerschensteiner M, Bareyre FM, Buddeberg BS. et al. Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis. J Exp Med 2004; 200 (8) 1027-1038
    CrossrefPubMedGoogle Scholar